Clinical Trial Update: An Extension Study to Evaluate the Long-Term Safety and Efficacy of Votoplam in Participants With Huntington's Disease (HD) [Phase 2]

View source ↗

Summary

An extension of a Phase 2 study to evaluate the long-term safety and efficacy of Votoplam in Huntington's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Huntington Disease

Drugs mentioned

• Votoplam

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Huntington Disease | Phase 2 | Status: ACTIVE_NOT_RECRUITING